 |
 
| Speakers
and Panelists: - Never
before such an assembly of the great minds in
nanotechnology |
|
Corning, Dr. Joydeep Lahiri, Research Director, Biotechnical Technologies
Project leader, label independent detection project, development of the Epic ™ system. Research contributions include invention of GPCR microarrays and lanthanide-doped microbarcodes. Formerly Senior research scientist, Science and Technology. Group Leader, High Sensitivity Assays. Research manager, Biochemical Technologies, Organic and Biochemical Technologies Directorate.
B.A., St. Stephen's College, Delhi; M.A., Indian Institute of Technology, Kanpur; PhD., Chemistry, Princeton University.
|
|
pSivida Limited, Gavin J Rezos, CEO
Bio-nanotech company in joint venture with the
UK Government agency, QinetiQ, to develop BioSiliconT
products on controlled drug delivery. Principal
of Viaticus Capital Pty Ltd, funding technology
projects in Australia and the UK with links to
venture capital in the US. Investment banking
consultant to HSBC in Dubai. Has held regional
positions in London, Dubai and Sydney. HSBC is
one of the world's largest financial institutions.
Also speaks on Nanotechnology at conferences in
Frankfurt, Beijing, Toronto, Cairns and Sydney.
|
|
Accelrys NanoBiology Initiative, Deepak Singh, Ph.D.,
Director Director of Accelrys' advanced
technology initiative in nanobiology. Focused
on developing and commercializing software solutions
to solve problems pertaining to the interaction
of nanomaterials and biological systems. Prior
to this position, was responsible for Life sciences
simulation products at Accelrys. Formerly scientific
programmer at GeneFormatics,Inc. Developed software
for threading and low-resolution simulations of
proteins at a genomic scale. M.Sc. in Physical
Chemistry, Indian Institute of Technology-Bombay,
focused on zeolites and molecular electronics.
Ph.D. in Physical Chemistry, Syracuse University
with Prof. Robert Birge. Research in application
of electronic structure theory, DFT and molecular
dynamics simulations on the structure and photophysics
of polyenes and retinal proteins, and on molecular
electronics applications of bacteriorhodopsin.
|
|
Johns Hopkins University School of Medicine, Dr.
Jonathan Javitt, Senior Adjunct Fellow
Dr. Jonathan Javitt is a Senior Fellow of the
Potomac Institute for Policy Studies and an adjunct
Professor of the Johns Hopkins University School
of Medicine. In May 2003, Dr. Javitt was appointed
by President George W. Bush to the President's
Information Technology Advisory Committee, where
he chairs the subcommittee on health information
technology. Dr. Javitt is also Vice-Chairman of
Health Directions, LLC a Bethesda-based investment
group that focuses on developing computer solutions
to improve the delivery of Health Care. He is
Chief Scientific Officer of Active Health Management,
Inc. |
|
BioForce Nanosciences; Saju Nettikadan, Director of Research and Applications Development
Formerly BioForce Nanosciences, research scientist, involved in the development of AFM based technologies for high throughput molecular screening. Involved in the development of NanoArrayer instrumentation and application development.
Ph.D., Ohio State University, Medical Biochemistry
|
|
Arrowhead Research; R. Bruce Stewart, Chief Executive Officer
Formerly, Acacia Research Corporation, founder; Annandale Securities, president.
Arrowhead Research Corporation combines capital and talent for finding early-stage technology with commercial potential.
|
|
eMembrane, Inc; William Lee, President & CEO
Leading scientist in the field of nano-grafting technology. Inventor, 14 patent applications related to his works. Postdoctoral fellow, Harvard Medical School/Massachusetts General Hospital, gene therapy research.
B.A., M.A., and PhD., Chemical Engineering, University of Tokyo.
|
|
HORIBA Jobin Yvon Inc; Dr. Andrew Whitley, V.P. and Director, Raman Spectroscopy Division
Formerly Renishaw and Bruker, global marketing and sales support. Member, Society for Applied Spectroscopy; member, Coblentz Society; member, Royal Society of Chemistry, and UK Infrared and Raman Discussion Group.
B.Sc. and Ph.D., Chemistry, University of Durham, UK.
|
|
FEI Company; Jens Greiser, Manager, Strategic Marketing
Manager of Strategic Marketing, FEI Company's Research, Industry and Biology markets.
B.S, Solid State Physics; PhD, Materials Sciences, University of Stuttgart.
|
|
NanoMaterials Technology; Dr Jimmy Yun, CEO
Specializes in development and commercialization of production technologies for nanomaterials in the pharmaceutical, electronics and chemical sectors.
Formerly Natsteel Chemicals; National Science & Technology Board (NSTB), Singapore; Research fellow, Hokkaido National Industrial Research Institute, Japan; Specialty Separation Centre, Georgia Institute of Technology.
PhD, University of New South Wales, Australia
|
|
TheraCour; Anil R. Diwan, Chairman and President
Inventor, TheraCour technology that enables NanoViricides drugs.
Developed nanomaterials that are capable of multi-specific multi-targeting of viruses, and of encapsulating active pharmaceutical ingredients (API) in industry-leading payload capacities.
B.Tech., Indian Institute of Technology, Bombay, India; Ph.D., Rice University, TX.
|
|
Venture Development Associates; Michael Moradi, Managing Director
Co-Founder and Vice President, SouthWest NanoTechnologies. Founded several nanotech and biotech startups including Venture Development Associates. Formerly Vice President of Business Development, NanoSource Technologies. 2003 community service commendation, United States Congress for voluntary efforts in technology-based economic development.
Bachelor of Science, Biochemistry, University of Oklahoma
|
|
|
Asylum Research; Dr. Deron Walters, Applications Scientist
Specializes in the physics of AFM and optical microscopy techniques, also specializing in combining confocal and AFM microscopies for life science applications.
B.A., California Institute of Technology; Ph.D., University of California, Santa Barbara.
|
|
Hemobiotech, Inc., Dr. Arthur Bollon, Chairman and CEO
HemoBioTech, Inc., a company which is developing HemoTech™, a novel substitute for human blood. Dr. Bollon has 25 years experience in biotechnology as an entrepreneur, scientist and executive. He founded and has served as Chairman and CEO of several biotech companies where he raised over $70 million, acquired Nobel Prize based drug design technology and completed deals with several companies including Bristol Meyers Squibb.
Dr. Bollon has a Ph.D. from Rutgers and was a Postdoctoral Fellow at Yale University.
|
|
University of Texas, Southwestern; Dr Harold R. "Skip" Garner, Professor, Biochemistry and Internal Medicine
Founding member, The Institute for Development and Application of Advanced Technologies. Member, McDermott Center for Human Growth and Development (Human Genetics Center); Founding member, Center for Biomedical Inventions; Founder, Helix, BioAutomation, Nimblegen, and etexx Biopharmaceuticals.
BS, Nuclear Engineering, University of Missouri, Rolla; Ph.D., plasma/high temperature matter physics, University of Wisconsin, Madison.
|
|
University of Texas, Southwestern; Dr Joshua Stern, Department of Urology
Nanotechnology research includes development of specific surgical applications for. Recipient of fellowships from the American Federation for Aging Research and the Cornell Molecular Biology department.
Undergraduate degree, University of Pennsylvania; Medical degree, Weill Cornell Medical College.
|
|
University of Texas Health Science Center at Houston,
Mauro Ferrari, Prof. Dept. of Internal Medicine,
Div. of Cardiology Founder of the fields
of biomedical nano- and micro-technology (bioMEMS),
and a pioneer of their applications to medical
therapeutics in sectors such as drug delivery,
proteomic nanotechnology, cell transplantation,
and tissue engineering. His particular interest
is in oncology, cardiovascular disease and diabetes.
His group was the first to successfully perform
the implantation of hybrid chips (biological cells
included in immunoprotective silicon microchips)
into animal models. Also works in biosensors and
bioseparation technology, multiscale discrete/continuum
mechanics and biomechanics; bioethics; fracture
and failure mechanics; the mechanics of composite
materials and structures; eigen-elasticity; homogenization
theory; and functionally graded materials. |
|
University of Texas at Dallas, Dr. Rockford Draper,
Professor Dr. Draper is a professor
at the University of Texas at Dallas with joint
appointments in the Department of Molecular &
Cell Biology and the Chemistry Department. He
is also a member of the NanoTech Institute and
the Institute of Biomedical Sciences and Technology.
His research interests include membrane cell biology
and developing the interface between cell biology
and nanotechnology. In 2002 he initiated the Bionanosciences
Group at UT Dallas that brings together chemists,
nanotechnologists, engineers, and biologists to
explore biological applications of nanotechnology.
|
|
UT Dallas, Dr. Gregg Dieckmann, Associate Professor,
Chemistry Research in inorganic chemistry,
biochemistry and biophysics. insights into the
functioning of biological membrane fusion, a process
required for viral infection, intracellular transport
and neurotransmitter release. Also small protein
domains that can bind to helical membrane fusion
proteins and possible antiviral agents against
HIV, influenza, etc. Is probing the molecular
basis of gene regulation and DNA repair to control
gene expression. Also designing small metal-binding
domains as models for naturally occuring metalloproteins.
Targets include the metalloregulatory protein
merR which binds mercury and is involved in heavy
metal detoxification in bacteria, and the Zn-containing
Ada demethylase, which repairs methylation damage
in E. coli.
Assistant Professor. Collaborative interactions
with researchers at DuPont-Merck Pharmaceuticals,
Wilmington, DE (1992-1996). |
|
UT Dallas, Dr. Inga Musselman, Associate Professor,
Chemistry Scanning probe microscopy
(SPM), image contrast mechanisms, limits of image
contrast resolution, and causes of molecular alignment
on surfaces. Determining which similar atoms may
be differentiated by contrast in STM and AFM images.
Also the application of SPM to the study of polymer
surface microstructure. Microstructural analyses
by SPM for polypeptide molecules, for Langmuir-Blodgett
polypeptide thin films, expected as an effective
medium for advances in (opto-) electronic devices,
for conducting polymer membranes for the separation
of gases important to coal and energy technology,
and for paired helical filaments which constitute
the neurofibrillary tangles and senile plaques
of Alzheimer diseased brains. |
|
The University of Texas at Dallas, Dr. Paul Pantano, Associate Professor, Chemistry
Bio-analytical chemist. Expertise in chemical microscopies,
optical and electrochemical sensors and arrays, chemically-modified
surfaces, and in situ biological measurements such as monitoring
the oxidative stress response of individual cells and tissue.
Collaborative efforts with The UTD Bio-nanosciences Group involve
investigating the bio-compatibility and intracellular fate of SWCNTs.
|
|
Texas Scottish Rite Hospital for Children, Dr. Mario
Romero-Ortega, Ph.D, Director
Regenerative Neurobiology, Seay Research
Center
Evaluation of carbon nanotubes sheets as conductive
substrates for cellular growth. Also focused on
methods to direct nerve regeneration in the peripheral
nervous system and spinal cord. Currently leads
a team developing biosynthetic nerve prosthesis
grafts for peripheral nerve gap repair. Also working
towards fully functional bi-directional, sensory/motor
peripheral neuro-electrical interfaces. Helped
define the molecular mechanisms that guide development
of nerve circuits in the spinal cord and possible
genetic cause of rare human condition, congenital
mirror movement disorder.
Also assistant Professor of Neurology and Biomedical
Engineering at the University of Texas Southwestern
Medical Center, in Dallas. |
|
UTSW Medical Center and UT Dallas, Dr. Jinming Gao
Professor University of Texas Southwestern
Medical Center, Jinming Gao, Ph.D, Associate Professor
of Biomedical Engineering and Radiology, Case
Western Reserve University.
Extensive study in the treatment of tumors. Developing
ß-lapachone-containing nanoparticle micelles
and examining the Pharmacokinetics and Pharmacodynamics
of ß-lapachone delivered by nanoparticle
micelles. Also examing the antitumor efficacy
of ß-lapachone-containing micelles.
Beijing University, Beijing, China, B.S., 1991,
Chemistry, Highest Honor, Guanghua Fellowship
to B.Sc., Beijing University; Harvard University,
Cambridge, MA; Harvard University, Cambridge,
MA, PostDoc, 1998, Biomedical Engineering. |
|
 |
.jpg){kind=small}
.jpg)
